publication venue for
- Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation. 08:e121-e131. 2024
- Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation. 08:e1-e1. 2024
- Potential for a Virtual Care Model in the Perioperative Management of Anticoagulant Therapy: A 5-Year Retrospective Clinic Review. 07:e184-e190. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. 7:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. 7:e105-e109. 2023
- High Factor VIII Levels and Recurrent Thromboembolism in Patients with and without Inflammatory Bowel Disease: A Retrospective Comparative Study. 06:e147-e153. 2022
- Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study. 06:e10-e17. 2022
- Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis. 05:e438-e448. 2021
- Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review. 05:e461-e469. 2021
- Prognostic Factors for Venous Thromboembolism in Patients with Solid Tumours on Systemic Therapy: A Systematic Review. 05:e461-e469. 2021
- Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?. 05:e84-e88. 2021
- Effect of Direct Oral Anticoagulant, Patient, and Surgery Characteristics on Clinical Outcomes in the Perioperative Anticoagulation Use for Surgery Evaluation Study. 04:e255-e262. 2020
- Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation. 02:e190-e201. 2018
- Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial. 01:e139-e145. 2017
- Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery. 01:e82-e91. 2017